乳腺癌 - 医索

找到约 32963 条结果

Are we on BEAT

医客学院 - 会议报告集

Amivantamab plus lazertinib vs osimertinib infirst-line EGFR-mutant advanced non-small cell lungcancer(NSCLC)with biomarkers of high-risk diseaseA secondary analysis from the phase 3 MARIPOSA study

医客学院 - 会议报告集

Amivantamab plus lazertinib in atypical EGFR-mutatedadvanced non-small cell lung cancer (NSCLC)Results from CHRYSALIS-2

医客学院 - 会议报告集

Amivantamab and lazertinib inpatients with EGFR-mutant lungcancers and CNS disease

医客学院 - 会议报告集

Adjuvant icotinib of 12 months or 6 months versus observationfollowing adjuvant chemotherapy for resected EGFR-mutatedstage ll-lllA non-small-cell lung cancer (ICTAN, GASTO1002) arandomized phase 3 trial

医客学院 - 会议报告集

A Phase ll Randomized Trial Evaluating ConsolidativeNivolumab in Locally Advanced Non-Small Cell LungCancer Post Neoadjuvant Nivolumab plus Chemotherapyand Concurrent chemoradiotherapy (CA209-7AL)

医客学院 - 会议报告集

A Multinational Pivotal Study of Sunvozertinib inPlatinum Pre-treated Non-Small Cell Lung Cancerwith EGFR Exon 20 Insertion MutationsPrimary Analysis of WU-KONG1 Study

医客学院 - 会议报告集

Updated results from the Phase 1b2 HERKULES-3 studyERAS-007 plus encorafenib and cetuximab (Ec)inpatients (pts)with EC-naive metastatic BRAF V600Ecolorectal cancer (CRC)

医客学院 - 会议报告集

Total neoadjuvant treatment with long-course radiotherapyversus concurrent chemoradiotherapy in local advanced rectalcancer with high risk factors (TNTCRT)A multicenter,randomized, open-label, phase

医客学院 - 会议报告集

Time dependency for HPV ctDNAdetection as a prognostic biomarkerfor anal cancer

医客学院 - 会议报告集

今日实时热搜